Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: an overview and update on new developments
Mohammad Yasin ZamanianDepartment of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, 6718773654, IranRosario Mireya Romero‐ParraDepartment of General Studies, Universidad Continental, Lima, PeruAfsaneh SoltaniSchool of Medicine, Iran University of Medical Sciences, Tehran, IranMałgorzata KujawskaDepartment of Toxicology, Poznan University of Medical Sciences, Dojazd 30, Poznan, 60-631, PolandYasser Fakri MustafaDepartment of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, IraqGhaidaa RaheemNeurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, 6718773654, IranLateef Al-AwsiHolya A. LaftaDepartment of Pharmacy, Al-Nisour University College, Baghdad, IraqNiloofar TaheriSchool of Medicine, Shahroud University of Medical Sciences, Shahroud, IranMahsa HeidariDepartment of Biochemistry, Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran, IranMaryam GolmohammadiSchool of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IranGholamreza BazmandeganDepartment of Physiology and Pharmacology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. [email protected]
2023en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба